BioWorld

Dec. 18, 2003

View Archived Issues

BioNumerik Placement Raises $29M For Oncology Research

BioNumerik Pharmaceuticals Inc. is topping off 2003 with more than $35 million in cash, thanks to a $29 million private placement with existing investors. (BioWorld Today) Read More

Peninsula IPO Aims To Raise $86.25M For Antibiotic Work

Read More

Belgian Kemin Pharma Signs Pact With U.S. Army To Brave BioTerror Threat Involving Smallpox, SARS

Read More

Angling For Profitability, Guava Raises $27M In Series D Round

Read More

Other News To Note

Read More